AVASOPASEM MANGANESE
Stereotactic Body Radiation Therapy
Galera Therapeutics, Inc.Small moleculePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 37/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Stereotactic Body Radiation Therapy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Catequentinib Peking University Third Hospital | Phase 2 | CCC |
Eloxatin Beijing 302 Hospital | D | |
Ethiodized Oil Beijing 302 Hospital | D | |
Theprubicin Beijing 302 Hospital | D |
Same molecule, other indications
AVASOPASEM MANGANESE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →